Fate Therapeutics is seeking an experienced clinical translation Physician / Scientist with scientific and clinical expertise in hematology / oncology to develop and drive innovative healthcare approaches and opportunities across Fate’s clinical programs. This role will lead clinical biomarker discovery providing guidance and direction in the conceptualization, development, and implementation of translational biomarker strategies for current and future clinical programs for relevant diseases and programs. The successful candidate will have extensive knowledge and experience in integrating translational research and clinical development and development of biomarker strategy in alignment with clinical development objectives. This role will collaborate with the lab-based biomarker measurements team and will oversee integration, interpretation, and communication of data to relevant functional groups. The successful candidate will be responsible for understanding external research environments, ability to partner with discovery biology and other teams both internally and externally to execute the clinical translation deliverables. This role will also engage functional groups across the organization to develop, champion, implement and align biomarker strategies for development projects in support of the overall R&D portfolio goals. This is a full-time position located at our corporate headquarters in San Diego, CA reporting to the
Senior Vice President, Clinical Translation.
Working Conditions and Physical Requirements
The preceding job description indicates the general nature and level of work performed by employees within this classification. Additional and incidental duties related to the primary duties may be required from time to time.
For consideration send cover letter and curriculum vitae to: www.fatetherapeutics.com and reference job 384SC.
About Fate Therapeutics, Inc.
Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to the development of first-in-class cellular immunotherapies for cancer and immune disorders. The Company has established a leadership position in the clinical development and manufacture of universal, off-the- shelf cell products using its proprietary induced pluripotent stem cell (iPSC) product platform. The
Company’s immuno-oncology product candidates include natural killer (NK) cell and T-cell cancer immunotherapies, which are designed to synergize with well-established cancer therapies, including immune checkpoint inhibitors and monoclonal antibodies, and to target tumor-associated antigens with chimeric antigen receptors (CARs). The Company’s immuno-regulatory product candidates include ProTmune™, a pharmacologically modulated, donor cell graft that is currently being evaluated in a Phase 2 clinical trial for the prevention of graft-versus-host disease, and a myeloid- derived suppressor cell immunotherapy for promoting immune tolerance in patients with immune disorders. Fate Therapeutics is headquartered in San Diego, CA. For more information, please visit www.fatetherapeutics.com.
Job Type: Full-time